home← all complexes Ir builderC^N familiesD-MPNN

Complex #5782 — Ir(3) [IrPpy@L1]

2D Structure

Structure
⬇ MOL V3000

Info

ID5782
MetalIr
Oxidation state3
Charge1
Donor atoms{"N": 6}
AbbreviationIrPpy@L1
SMILESO=C(OCc1ccnc(-c2cc(COC(=O)c3cc4cc(Cl)ccc4[nH]3)ccn2)c1)c1cc2cc(Cl)ccc2[nH]1.[c-]1ccccc1-c1ccccn1.[c-]1ccccc1-c1ccccn1

TUCAN

C52H36Cl2IrN6O4/(1-44)(2-42)(3-43)(4-45)(5-57)(6-47)(7-39)(8-49)(9-52)(10-40)(11-59)(12-48)(13-58)(14-41)(15-50)(16-46)(17-55)(18-72)(19-71)(20-62)(21-83)(22-74)(23-54)(24-73)(25-60)(26-83)(27-61)(28-84)(29-64)(30-84)(31-51)(32-53)(33-63)(34-56)(35-89)(36-90)(37-41)(37-65)(38-50)(38-68)(39-43)(39-44)(40-42)(40-72)(41-43)(42-47)(44-65)(45-48)(45-50)(46-49)(46-51)(47-75)(48-62)(49-76)(51-73)(52-66)(52-87)(53-69)(53-79)(54-66)(54-77)(55-57)(55-87)(56-67)(56-88)(57-78)(58-61)(58-80)(59-69)(59-71)(60-67)(60-82)(61-88)(62-68)(63-70)(63-81)(64-70)(64-74)(65-75)(66-78)(67-80)(68-76)(69-83)(70-84)(71-91)(72-92)(73-93)(74-94)(75-92)(76-93)(77-85)(77-89)(78-89)(79-81)(79-91)(80-90)(81-94)(82-86)(82-90)(83-97)(84-98)(85-95)(85-97)(86-96)(86-98)(87-99)(88-100)(91-101)(92-101)(93-101)(94-101)(97-101)(98-101)

Measurements (5)

Cell lineIC₅₀ dark (µM)IC₅₀ light (µM)DOIYear
HCT-1164.2— 10.1021/acs.inorgchem.4c03950 2024
HepG26— 10.1021/acs.inorgchem.4c03950 2024
HeLa7.3— 10.1021/acs.inorgchem.4c03950 2024
A54911— 10.1021/acs.inorgchem.4c03950 2024
WRL68—— 10.1021/acs.inorgchem.4c03950 2024

🧬 Cell Death Types (1)

Apoptosis high
«activate a cascade of mitochondria-mediated cell death events, and arrest the cell cycle in S-phase which leads to apoptosis.»

Source-assisted 2D generator

Builds the drawing from source ligand graphs and explicit donor metadata, then uses Metal2D only for layout. Publication output uses black bonds without arrows or colour highlighting; validated octahedral enantiomers are encoded directly with solid and hashed wedge bonds.

experimental validation surface
Loading source metadata…
The generated SVG will appear here. The legacy ligand image above stays visible for side-by-side review.